HARVARD BIOSCIENCE, INC. (HBIO) Debt Components
- 2026-06-30: Secured Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $36.68M; Long-term DebtUSD $36.68M.
- 2026-03-31: Secured Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $36.21M; Long-term DebtUSD $36.21M.
- 2025-12-31: Secured Debt, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $35.87M; Long-term DebtUSD $35.87M.
- 2025-12-31: Secured Debt, CurrentUSD $0.00; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
HARVARD BIOSCIENCE, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Secured Debt, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Line of Credit Facility, Interest Rate at Period End pure | Long-term Debt, Gross USD | Secured Debt USD | Long-term Line of Credit USD | Line of Credit Facility, Maximum Amount Outstanding During Period USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Remaining Borrowing Capacity USD | Debt Instrument, Face Amount USD | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $0.00 | $36.68M | $36.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $0.00 | $36.21M | $36.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $0.00 | $35.87M | $35.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | (m) | (m) | (m) | $0.00 | $1.62M | $6.50M | $31.88M | $0.00 | $0.00 | (m) | $40.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $33.97M | (m) | (m) | $33.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 10.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $34.86M | (m) | (m) | $34.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $35.96M | (m) | (m) | $36.40M | (m) | (m) | (m) | (m) | (m) | (m) | 8.60% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $36.96M | $36.96M | $0.00 | $36.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.40% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | $34.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.61M | $4.00M | $34.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.60% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $3.72M | $4.00M | $31.96M | $35.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $3.72M | $4.00M | $31.89M | $35.61M | $4.00M | $32.10M | (m) | (m) | (m) | (m) | (m) | $36.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $36.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $5.86M | $6.14M | $30.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | $6.14M | $30.98M | (m) | (m) | (m) | (m) | (m) | $37.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $3.47M | $3.75M | $35.27M | $38.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $3.22M | $3.50M | $38.20M | $41.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $2.97M | $3.25M | $41.08M | $44.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $3.81M | $4.09M | $43.01M | $46.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $4.09M | $4.00M | $39.57M | (m) | (m) | (m) | (m) | $47.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $2.72M | $3.00M | $46.53M | $49.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $2.72M | $3.00M | $45.76M | $48.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $2.72M | $3.00M | $46.24M | $48.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $3.23M | $3.52M | $45.09M | $48.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $3.52M | $3.00M | $4.00M | $38.94M | (m) | (m) | (m) | $49.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $2.47M | $2.75M | $42.74M | $45.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $2.22M | $2.50M | $40.92M | $43.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $1.97M | $2.25M | $41.60M | $43.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.72M | $2.00M | $46.29M | $48.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | $2.00M | $3.00M | $3.00M | $4.00M | $37.40M | (m) | (m) | $49.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $2.81M | $3.20M | $40.67M | $43.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $2.81M | $3.20M | $40.92M | $43.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $2.81M | $3.20M | $46.28M | $49.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $6.90M | $3.20M | $46.92M | $53.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $7.29M | $3.20M | $3.20M | $41.30M | (m) | (m) | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $2.61M | (m) | $51.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $54.32M | (m) | (m) | (m) | $9.40M | (m) | (m) |
| 2019-06-30 | $2.41M | (m) | $52.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $54.82M | (m) | (m) | (m) | $9.50M | (m) | (m) |
| 2019-03-31 | $2.21M | (m) | $54.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $56.34M | (m) | (m) | (m) | $14.50M | (m) | (m) |
| 2018-12-31 | $5.98M | $2.40M | $54.81M | $60.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $60.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $2.40M | $3.20M | $3.20M | $3.20M | $50.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.80M | (m) | (m) |
| 2018-09-30 | $1.80M | (m) | $59.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $61.05M | (m) | (m) | (m) | $8.50M | (m) | (m) |
| 2018-06-30 | $1.62M | (m) | $59.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $61.45M | (m) | (m) | (m) | $8.60M | (m) | (m) |
| 2018-03-31 | $1.41M | (m) | $61.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $62.98M | (m) | (m) | (m) | $14.60M | (m) | (m) |
| 2018-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) |
| 2018-01-31 | (m) | (m) | (m) | $11.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $14.50M | $64.00M | (m) |
| 2018-01-22 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.90M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $2.77M | (m) | $8.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.75M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $11.90M | $11.90M | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $2.77M | (m) | $9.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.44M | (m) | (m) | (m) | $5.50M | (m) | (m) |
| 2017-06-30 | $2.78M | (m) | $10.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.20M | (m) | (m) | (m) | $5.30M | (m) | (m) |
| 2017-03-31 | $2.72M | (m) | $10.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.65M | (m) | (m) | (m) | $5.20M | (m) | (m) |
| 2016-12-31 | $2.37M | (m) | $11.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.75M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $13.85M | $2.45M | $11.40M | $0.00 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.70M | (m) | (m) |
| 2016-09-30 | $2.37M | (m) | $12.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $15.04M | (m) | (m) | (m) | $7.80M | (m) | (m) |
| 2016-06-30 | $2.39M | (m) | $13.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.16M | (m) | (m) | (m) | $6.30M | (m) | (m) |
| 2016-03-31 | $2.38M | (m) | $14.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.15M | (m) | (m) | (m) | $4.40M | (m) | (m) |
| 2015-12-31 | $2.36M | (m) | $16.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $18.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $18.90M | $2.45M | $2.45M | $14.00M | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) |
| 2015-09-30 | $5.00M | (m) | $15.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $20.15M | (m) | (m) | (m) | $5.60M | (m) | (m) |
| 2015-06-30 | $5.00M | (m) | $15.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $20.65M | (m) | (m) | (m) | $8.50M | (m) | (m) |
| 2015-03-31 | $5.00M | (m) | $16.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.90M | (m) | (m) | (m) | $6.20M | (m) | (m) |
| 2014-12-31 | $5.00M | (m) | $16.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.45M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | $21.45M | $5.00M | $9.20M | $5.00M | $2.25M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.80M | (m) | (m) |
| 2014-09-30 | $5.00M | (m) | $18.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $23.20M | (m) | (m) | (m) | $20.30M | (m) | (m) |
| 2014-06-30 | $5.00M | (m) | $17.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.25M | (m) | (m) | (m) | $21.60M | (m) | (m) |
| 2014-03-31 | $5.00M | (m) | $18.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $23.50M | (m) | (m) | (m) | $19.10M | (m) | (m) |
| 2013-12-31 | $5.00M | (m) | $19.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.75M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $24.75M | $5.00M | $5.00M | $7.50M | $5.00M | $2.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.40M | (m) | (m) |
| 2013-09-30 | $3.00M | (m) | $20.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $23.50M | (m) | (m) | (m) | $25.00M | (m) | (m) |
| 2013-06-30 | $3.00M | (m) | $21.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.30M | (m) | (m) | (m) | $25.00M | (m) | (m) |
| 2013-03-31 | $3.00M | (m) | $12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | $15.00M |
| 2013-03-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) |
| 2013-03-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | (m) | $12.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.95M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.00M |
| 2012-12-31 | (m) | (m) | (m) | $12.95M | (m) | (m) | (m) | (m) | (m) | (m) | 3.21% | (m) | (m) | (m) | (m) | $20.00M | $7.00M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $15.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.22% | (m) | (m) | (m) | (m) | $20.00M | $4.70M | (m) | $15.30M |
| 2012-06-30 | (m) | (m) | $16.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) | (m) | (m) | $20.00M | $3.90M | (m) | $16.10M |
| 2012-03-31 | (m) | (m) | $16.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $16.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $16.30M |
| 2011-09-30 | (m) | (m) | $16.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $17.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $18.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |